, -La situation du cancer en France en 2011. Institut National du Cancer, collection rapports et synthèses. Octobre, 2011.

J. Cohen, P. Madelenat, and R. Levy-toledano, Gynécologie et santé des femmes, quel avenir en France ?, Etat des lieux et perspective en 2020. Paris : éditions ESKA, Juin 2000, 188p 4-Article dans « Le Monde » du 27 décembre 2017 : « Consulter un gynécologue : la grande galère

, /2010, modifiant l'arrêté du 11/4/2008, relatif aux règles de bonnes pratiques cliniques et biologiques d'assistance médicale à la procréation

;. France/epidemiologie, . Hcl, . Santé-publique-france, . Inca, and F. Binder-foucard, Cancers/Donnees-par-localisation/Cancer-du-col-de-l-uterus 13-Survie des personnes atteintes des cancers en France métropolitaine de 1989-2013 14-Francim, Hospices civils de Lyon, des-cancers/Les-cancers-les-plus-frequents/Cancer-du-sein 10-Francim, Hospices civils de Lyon, Institut national du cancer, structures de gestion du dépistage 11-Partenariat Francim, vol.15, pp.3-30, 2003.

E. Desandes, J. Clavel, C. Berger, and J. L. Bernard, Cancer incidence among children in France, 1990-1999. Pediatr Blood Cancer, vol.43, pp.749-57, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-00264777

, 25-Institut national du cancer, « les cancers en France en 2015, l'essentiel des faits et chiffres, p.2015

B. Courbière, J. Perrin, B. Conte-devoix, and T. Brue, Contrôle génétique du capital folliculaire, pp.5-40, 2013.

K. R. Hansen, N. S. Knowlton, A. C. Thyer, and J. S. Charleston, A new model of reproductive aging: the decline in ovarian non growing follicle number from birth to menopause, Hum Reprod, vol.23, pp.699-708, 2008.

W. H. -wallace and T. W. Kelsey, Human ovarian reserve from conception to the menopause 29-Te Velde, Molecular et cellular endocrinology, vol.10, issue.6, 1998.

D. Ziegler, D. Streuli, I. Decanter, C. This, P. Chapron et al., Cancer and fecunity issues mandate a multidisciplinary approach, Fertility and Sterility, vol.93, pp.3-691, 2009.

L. Singh, K. Davies, M. Chatterjee, and R. , Fertility in Female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing, Hum reprod Update, vol.11, pp.69-89, 2005.

S. M. -swain, S. R. Land, M. W. Ritter, J. P. Costantino, R. S. Cecchini et al.,

, Amenorrhea in premenopausal women on the dexorubicin-and-cyclophosphamide-followedby-docetaxel arm of NSABP B-30 trial, Breast Cancer RES Treat, vol.113, pp.315-335, 2009.

D. Wunder, L. Perey, C. Achtari, A. Ambrosetti, and M. Bellavia, Gonadotoxité des agents chimiothérapeutiques, Fertiliy preservation in cancer patients: Review of the French speaking part of Switzerland and recommandations for differents situations, The European Journal of Medical Sciences, vol.142, p.13645, 2012.

A. -goldhirsch, R. D. Gelber, and M. Castiglione, The International Breast Cancer Study Group

J. Byrne, T. R. Fears, M. H. Gail, D. Pee, and R. R. Connelly, Early menopause in long-term survivors of cancer during adolescence, Am J Obstet Gynecol, vol.166, pp.788-93, 1992.

H. Koyama, T. Wada, Y. Nishizawa, T. Iwanaga, and Y. Aoki, Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer, Cancer, vol.39, pp.1403-1412, 1977.

E. C. Larsen, J. Muller, K. Schmiegelow, C. Rechnitzer, N. Andersen et al., Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer, J Clin Endocrinol Metab, vol.88, pp.5307-5321, 2003.

L. E. 38-bath, W. H. Wallace, M. P. Shaw, C. Fitzpatrick, and R. A. Anderson, Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound, Hum Reprod, vol.18, pp.2368-74, 2003.

M. A. -van-der-kaaij, N. Heutte, P. Meijnders, E. Abeillard-lemoisson, M. Spina et al.,

, Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study, J Clin Oncol, vol.30, pp.291-300, 2012.

W. H. Wallace, R. A. Anderson, D. S. Irvine, M. D. ;--green, T. Kawashima et al., Ovarian Failure and Reproductive Outcomes After Childhood Cancer Treatment: Results From the Childhood Cancer Survivor Study, J Clinic Oncol, vol.6, pp.2374-81, 2005.

A. M. -chiarelli, L. D. Darlington, and G. , Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada, Am J Epidemiol, vol.150, issue.3, pp.245-54, 1999.

W. H. Wallace, A. B. Thomson, F. Saran, and T. W. Kelsey, Predicting age of ovarian failure after radiation to a field that includes the ovaries, Int J Radiation Oncol Bio Phys, vol.62, pp.738-782, 2005.

H. -letur-kornisch, J. L. Lefaix, and S. Delanian, Uterus after irradiation, Gynecol Obstet Fertil, vol.33, pp.605-614, 2005.

W. H. -wallace, A. B. Thomson, and T. W. Kelsey, The radiosensitivity of the human oocyte, Human reproduction, vol.18, pp.117-138, 2003.

J. Donnez, B. Martinez-madrid, P. Jadoul, A. Van-langendonckt, D. Demylle et al., Ovarian tissue cryopreservation and transplantation: a review, Human reproduction update, vol.12, pp.519-554, 2006.

Z. Blumenfeld, I. Avivi, R. Epelbaum, M. Be-shahar, and N. Haim, Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophinreleasing hormone agonist in parallel to chemotherapy, Hum Reprod, vol.11, pp.1620-1626, 1996.

A. Badaway, Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study, Fertil Steril, vol.91, pp.694-701, 2009.

K. Oktay, M. Sönmezer, O. Oktem, K. Fox, G. Emons et al., Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury, Oncologist, vol.12, pp.1055-66, 2007.

H. -chen, J. Li, T. Cui, and L. Hu, Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women

, Cochrane Database Syst Rev, p.11, 2011.

B. Anderson, J. Lapolla, D. Turner, G. Chapman, and R. Buller, Ovarian transposition in cervical cancer, Gynecol Oncol, vol.49, pp.206-220, 1993.

, Assistance médicale à la procréation ». Dossier réalisé

M. Grynberg, H. Gynécologue-obstétricien-;--cakmak, A. Katz, M. I. Cedars, M. P. Rosen et al., Effective method for emergency fertility preservation : Random-start controlled ovarian stimulation, Estrogen carcinogenesis in breast cancer N Engl J Med, vol.782, issue.100, pp.270-282, 2006.

A. -ayhan, Association between fertility drugs and gynecologic cancers, breast cancer and childhood cancers Acta, Obstet Gynecol Scand, vol.83, pp.1104-1111, 2004.

M. Sonmeze and K. Oktay, Fertility preservation in young women undergoing, breast cancer therapy oncologist, vol.11, pp.422-434, 2006.

N. -chabbert-buffet, C. Uzan, J. Gligorov, S. Delaloge, R. Rouzier et al., Pregnancy after breast cancer: a need for global patient care, starting before adjuvant therapy, Surg Oncol, vol.19, pp.47-55, 2010.

K. -oktay, E. Buyuk, O. Davis, I. Yermakova, L. Veeck et al., Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen, Hum Reprod, vol.18, pp.90-95, 2003.

J. -reddy and K. Oktay, Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer, Fertil Steril, vol.98, pp.1363-1372, 2012.

C. Sifer, N. Sermondade, and C. Dupont,

M. Minasi and . Eshre--, , 2009.

D. G. Whittingham, S. P. Leibo, and P. Mazur, Survival of mouse embryos frozen to -196 degrees and -269 degrees C. Science, vol.178, pp.411-415, 1972.

P. Mazur, Cryobiology: the freezing of biological systems, Science, vol.168, issue.3934, p.49, 1970.

B. Lassalle, J. Testart, and J. P. Renard, Human embryo features that influence the success of cryopreservation with the use of 1,2 propanediol, Fertil Steril, vol.44, issue.5, pp.645-51, 1985.

J. Saragusty and A. Arav, Current progress in oocyte and embryo cryopreservation by slow freezing and vitrification. Reprod Camb Engl, vol.141, pp.1-19, 2011.

J. Liebermann, Vitrification of Oocytes and Embryos, Current Frontiers in Cryobiology. InTech, pp.169-84, 2012.

M. Kasai and T. Mukaida, Cryopreservation of animal and human embryos by vitrification

, Reprod Biomed Online, vol.9, issue.2, pp.164-70, 2004.

J. Saragusty and A. Arav, Current progress in oocyte and embryo cryopreservation by slow freezing and vitrification. Reprod Camb Engl, vol.141, pp.1-19, 2011.

A. -camus, P. Clairaz, A. Ersham, A. L. Van-kappel, G. Savic et al., The comparison of the process of five different vitrification devices. Gynécologie Obstétrique Fertil, 2006.

M. Kuwayama, G. Vajta, S. Ieda, and O. Kato, Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination, Reprod Biomed Online, vol.11, issue.5, pp.608-622, 2005.

K. E. Loutradi, E. M. Kolibianakis, C. A. Venetis, E. G. Papanikolaou, G. Pados et al., Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis, Fertil Steril, vol.90, issue.1, pp.186-93, 2008.

F. F. Abdelhafez, N. Desai, A. M. Abou-setta, T. Falcone, and J. Goldfarb, Slow freezing, vitrification and ultra-rapid freezing of human embryos: a systematic review and metaanalysis, Reprod Biomed Online, vol.20, issue.2, pp.209-231, 2010.

E. M. Kolibianakis, C. A. Venetis, and B. C. Tarlatzis, Cryopreservation of human embryos by vitrification or slow freezing: which one is better ?, Curr Opin Obstet Gynecol, 2009.

J. -uranga-chauvel, Comparaison des résultats de la vitrification et de la congélation lente des embryons au stade clive précoce (j2-j3): étude rétrospective cas-témoin, 2016.

M. Valojerdi, P. Eftekhari-yazdi, L. Karimian, F. Hassani, and B. Movaghar,

, Vitrification versus slow freezing gives excellent survival, post warming embryo morphology and pregnancy outcomes for human cleaved embryos, J Assist Reprod Genet, 2009.

G. A. Rama-raju, G. B. Haranath, K. M. Krishna, G. J. Prakash, and K. Madan, Vitrification of human 8-cell embryos, a modified protocol for better pregnancy rates, Reprod Biomed Online, vol.11, issue.4, pp.434-441, 2005.

Y. Li, Z. J. Chen, H. J. Yang, W. X. Zhong, S. Y. Ma et al., Comparison of vitrification and slow-freezing of human day 3 cleavage stage embryos: post-vitrification development and pregnancy outcomes, Zhonghua Fu Chan Ke Za Zhi, vol.42, issue.11, pp.753-758, 2007.

M. G. -wilding, C. Capobianco, N. Montanaro, G. Kabili, D. Matteo et al.,

, Human cleavage-stage embryo vitrification is comparable to slow-rate cryopreservation in cycles of assisted reproduction, J Assist Reprod Genet, vol.27, issue.9, pp.549-54, 2010.

B. Boquet, Préservation de la fertilité en cas de cancer du sein chez la femme jeune, 2011.

G. 81-fasano, I. Demeestere, and Y. Englert, 2012 -In Vitro Maturation of human ovocytes : before or after vitrification ?, J Assist Reprod Genet, vol.29, pp.507-519

J. E. -smitz, J. G. Thompson, and R. B. Glichrist, The promise of in vitro maturation in assisted reproduction and fertility preservation, Semin Reprod Med, vol.29, pp.24-37, 2011.

G. D. -rao, R. C. Chian, W. S. Son, L. Gilbert, and S. L. Tan, Fertility preservation in women undergoing cancer treatment, Lancet, vol.363, pp.1829-1859, 2004.

-. Seroka, Fertility and fertility preservation in digestive oncology, 1991.

J. Donnez, S. Silber, C. Y. Andersen, I. Demeestere, P. Piver et al., Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births, Ann Med, vol.43, pp.437-50, 2011.

M. Dorez, 2013 -Laparoendoscopic single-site ovariectomy : an indication of choice for ovariectomian cryopreservatiion, Grand Round, vol.13, pp.1-3

B. Courbière, 2007 -comment faire pour réaliser une ovariectomie pour cryoconservation ovarienne en vue d'une autogreffe de cortex ovarien, Gynecol Obstet Fertil, vol.35, p.2007

, Laparoscopic ovariectomy for whole uman ovary cryopreservation : technical aspects, Fertil Steril, vol.87, pp.971-976

B. Courbière, 2010 -Tumor cell contamination in ovarian tissue cryopreserved before gonadotoxic treatement : should we systemematically exclude an ovarian autograft in a cancer survivor, Bone Marrow transplant, vol.45, pp.1247-1255

M. M. -dolmans, C. Marinescu, P. Saussoy, A. Van-langendonckt, C. Amorim et al., 2010 -Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe, Blood, vol.116, pp.2908-2922

J. Donnez, M. M. Dolmans, D. Demylle, P. Jadoul, C. Pirard et al., Livebirth after orthotopic transplantation of cryopreserved ovarian tissue, Lancet, vol.364, pp.1405-50, 2004.

J. Donnez and M. M. Dolmans, Ovarian Cortex transplantation : 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice, Journal of assisted reproduction and genetics, vol.32, pp.1167-70, 2015.

A. K. Jensen, S. G. Kristensen, K. T. Macklon, J. V. Jeppesen, J. Fedder et al., Outcomes of transplantations of cryopreserved ovarian tissue to 41 women in

. Denmark, Human reproduction l2015, vol.30, pp.2838-2883

L. Préaubert, P. Poggi, M. Pibarot, J. Delotte, E. Thibault et al., Fertility preservation among patients with cancer : Report of a French regional practical experience, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, vol.42, pp.246-251, 2013.

-. Bonhomme and C. Moretti, Etat des lieux de la pratique gynécologique des médecins généralistes installés en Savoie et Haute-Savoie : une étude quantitative. Médecine humaine et pathologie. 2017. 99-Plan cancer, 2014.

, Préservation de la fertilité et cancer, estimation de la population concernée, fiche d'analyse, collection les données, institut national du cancer/agence de la biomédecine